The biggest stories of the day delivered to your inbox.

A phase 3 study of AstraZeneca’s ceralasertib has missed its primary endpoint, dealing another blow to efforts to use a synthetic lethal mechanism to overcome resistance to immuno-oncology drugs. The ...

Hi everyone. Today we’ve got a bonus issue of Game On featuring an interview about one of last week’s most exciting video-game announcements. Larian Studios has hit the big time. Until somewhat ...

Michael Block is a 14 time GLAM Award nominated writer, producer, and host of the podcast Block Talk. Throughout his time in the entertainment industry, he has worked on and off Broadway as a stage ...

D-Wave is taking a dual approach to quantum computing led by its annealing technology. IonQ is using a trapped-ion gate-based system. Both stocks remain speculative at this point. While most quantum ...

The next full moon will be a spectacular wolf supermoon, set to rise in constellation Gemini — amid the peak of the Quadrantid meteor shower — and shine all weekend. Here's when and what to know about ...

Jeremy has more than 2200 published articles on Collider to his name, and has been writing for the site since February 2022. He's an omnivore when it comes to his movie-watching diet, so will gladly ...

LOUISVILLE, Ky. (WAVE) - Though no one in the Bluegrass took home the major prize in the Christmas Eve drawing, three winning Powerball® tickets totaling $200,000 were sold in Kentucky. Two of the ...

When corporate strategist David Gobberdiel and pharmacist Ryan Tungate started living together in Chicago in 2013, they never intended to open their relationship, let alone their home, to a third ...

The new year will usher in several key changes to Medicare coverage, and seniors could see significant impact to their health care. While lower prescription drug costs are on the menu, seniors will ...

President Trump is expected to meet with Israeli Prime Minister Benjamin Netanyahu on Monday afternoon as leaders look to advance the second phase of the U.S.-brokered peace plan between Israel and ...

William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage biotechs in the bunch. The analysts’ selections for the upcoming year span ...